These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12562579)

  • 1. Reward value of cigarette smoking for comparably heavy smoking schizophrenic, depressed, and nonpatient smokers.
    Spring B; Pingitore R; McChargue DE
    Am J Psychiatry; 2003 Feb; 160(2):316-22. PubMed ID: 12562579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cigarette smoking status on delay discounting in schizophrenia and healthy controls.
    Wing VC; Moss TG; Rabin RA; George TP
    Addict Behav; 2012 Jan; 37(1):67-72. PubMed ID: 21963152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contingencies for change in complacent smokers.
    Lamb RJ; Morral AR; Kirby KC; Javors MA; Galbicka G; Iguchi M
    Exp Clin Psychopharmacol; 2007 Jun; 15(3):245-55. PubMed ID: 17563211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of the Perception of Smoking Health Risks in Smokers With or Without Schizophrenia.
    Kowalczyk WJ; Wehring HJ; Burton G; Raley H; Feldman S; Heishman SJ; Kelly DL
    J Dual Diagn; 2017; 13(1):29-35. PubMed ID: 27858591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Task persistence predicts smoking cessation in smokers with and without schizophrenia.
    Steinberg ML; Williams JM; Gandhi KK; Foulds J; Epstein EE; Brandon TH
    Psychol Addict Behav; 2012 Dec; 26(4):850-8. PubMed ID: 22642860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effort-based decision making varies by smoking status.
    Addicott MA; Wardle MC; Selig JP
    Psychopharmacology (Berl); 2020 Apr; 237(4):1081-1090. PubMed ID: 31900525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smoking habits, current symptoms, and premorbid characteristics of schizophrenic patients in Nithsdale, Scotland.
    Kelly C; McCreadie RG
    Am J Psychiatry; 1999 Nov; 156(11):1751-7. PubMed ID: 10553739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Smoking reduction and temporary abstinence: new approaches for smoking cessation].
    Le Houezec J; Säwe U
    J Mal Vasc; 2003 Dec; 28(5):293-300. PubMed ID: 14978435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-reported motivation to smoke in schizophrenia is related to antipsychotic drug treatment.
    Barr AM; Procyshyn RM; Hui P; Johnson JL; Honer WG
    Schizophr Res; 2008 Mar; 100(1-3):252-60. PubMed ID: 18178062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity in the Effects of Reward- and Deposit-based Financial Incentives on Smoking Cessation.
    Halpern SD; French B; Small DS; Saulsgiver K; Harhay MO; Audrain-McGovern J; Loewenstein G; Asch DA; Volpp KG
    Am J Respir Crit Care Med; 2016 Oct; 194(8):981-988. PubMed ID: 27064456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weight concerns among male smokers.
    Clark MM; Decker PA; Offord KP; Patten CA; Vickers KS; Croghan IT; Hays JT; Hurt RD; Dale LC
    Addict Behav; 2004 Nov; 29(8):1637-41. PubMed ID: 15451131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of smokers with a psychotic disorder and implications for smoking interventions.
    Baker A; Richmond R; Haile M; Lewin TJ; Carr VJ; Taylor RL; Constable PM; Jansons S; Wilhelm K; Moeller-Saxone K
    Psychiatry Res; 2007 Mar; 150(2):141-52. PubMed ID: 17289155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of heavy smokers.
    Wilson D; Wakefield M; Owen N; Roberts L
    Prev Med; 1992 May; 21(3):311-9. PubMed ID: 1614993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of smoking abstinence on visuospatial working memory function in schizophrenia.
    George TP; Vessicchio JC; Termine A; Sahady DM; Head CA; Pepper WT; Kosten TR; Wexler BE
    Neuropsychopharmacology; 2002 Jan; 26(1):75-85. PubMed ID: 11751034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced Influence of Monetary Incentives on Go/NoGo Performance During Smoking Abstinence.
    Lydon DM; Roberts NJ; Geier CF
    Nicotine Tob Res; 2015 Sep; 17(9):1178-81. PubMed ID: 25542919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perception of smoking risks and motivation to quit among nontreatment-seeking smokers with and without schizophrenia.
    Kelly DL; Raley HG; Lo S; Wright K; Liu F; McMahon RP; Moolchan ET; Feldman S; Richardson CM; Wehring HJ; Heishman SJ
    Schizophr Bull; 2012 May; 38(3):543-51. PubMed ID: 21041835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extinguishing the rewarding value of smoke cues: pharmacological and behavioral treatments.
    Rose JE; Behm FM
    Nicotine Tob Res; 2004 Jun; 6(3):523-32. PubMed ID: 15203786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The acceptability of physical activity programming within a smoking cessation service for individuals with severe mental illness.
    Faulkner G; Taylor A; Munro S; Selby P; Gee C
    Patient Educ Couns; 2007 Apr; 66(1):123-6. PubMed ID: 17184957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Momentary Associations Between Reported Craving and Valuing Health in Daily Smokers.
    MacLean RR; Martino S; Carroll KM; Smyth JM; Pincus AL; Wilson SJ
    Nicotine Tob Res; 2017 Jun; 19(6):716-722. PubMed ID: 28486711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug cue induced overshadowing: selective disruption of natural reward processing by cigarette cues amongst abstinent but not satiated smokers.
    Freeman TP; Morgan CJ; Beesley T; Curran HV
    Psychol Med; 2012 Jan; 42(1):161-71. PubMed ID: 21733292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.